Basing prescription drug payment on economic analysis: the case of Australia.
Drummond
M F
MF
University of York, United Kingdom.
D001315:Australia; D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics; D005544:Forecasting; D006076:Government; D017408:Guidelines as Topic; D007356:Insurance, Pharmaceutical Services / Q000331:legislation & jurisprudence / Q000592:standards*